Tag Archives: Policy

Television News Coverage of the UK Parliamentary Inquiry Report on Lariam in the Military

The British Parliament’s Defence Select Committee published its report, “An acceptable risk? The use of Lariam for military personnel” on Tuesday 24 May 2016. Here are several of the television news stories that followed the publication of this report. Advertisements

Posted in Advocacy, Media, Our Stories, Uncategorized | Tagged , , , , , , | Leave a comment

Johnny Mercer MP: “The Ministry of Defence has Betrayed Our Armed Forces’ Mental Health”

For many years, British service personnel have been treated with a controversial anti-malaria drug despite warnings issued by its manufacturer. The Commons defence select committee, of which I am a member, has heard from scientists, lawyers and servicemen to try … Continue reading

Posted in Advocacy, Media | Tagged , , , , , , , , , , | Leave a comment

British Parliamentary Inquiry: “Lariam Should be ‘Drug of Last Resort’ for Troops”

  Lariam, the anti-malarial drug sometimes prescribed to British troops, should be considered only as a drug of last resort, says the Defence Committee, in its report on the MoD’s use of the drug. Report: An acceptable risk? The use … Continue reading

Posted in Advocacy, Research | Tagged , , , , , , , , , | Leave a comment

General Richards: “If the Use of Lariam is Banned it Would Not Be Before Time”

Kim Sengupta, British armed forces set to ban most prescriptions of controversial anti-malarial drug Lariam, The Independent, 23 May 2016. A number of senior officers say that recognition of the dangerous side-effects that the use of Lariam  is long overdue. General … Continue reading

Posted in Advocacy, Media | Tagged , , , , , , , , , | Leave a comment

Congressman John Carter Proposes Support for Mefloquine Veterans by the U.S. Defense Centers of Excellence

The National Defense Authorization Act for Fiscal Year 2017 is currently being debated in U.S. Congress. During this debate Congressman John Carter (Texas) has proposed additional controls on the use of mefloquine by the Department of Defense, and expanding the Defense Centers … Continue reading

Posted in Advocacy, Research, Support | Tagged , , , , , , | Leave a comment

Association of the U.S. Navy: Policy Position on Mefloquine Toxicity

This is the Association of the United States Navy’s policy position on mefloquine toxicity, included in written testimony for the record to a recent Joint Hearing of the House and Senate Veterans’ Affairs Committee. Written Testimony for the Record by … Continue reading

Posted in Advocacy, Support | Tagged , , , , , , | 1 Comment

Professor Philip Morris – New Financial Transparency Arrangements Between Doctors and Drug Companies

In early 2015 the Australian Consumer and Competition Commission (ACCC) authorized a new Code of Conduct for Medicines Australia (representing the larger drug companies in Australia but not generic makers). This 18th Code Edition now includes making public all payments … Continue reading

Posted in Advocacy, Clinical Drug Trials, Media | Tagged , , , | Leave a comment

Leonard Benton – Veteran Kills Himself At the VA: A Failure Written In Blood

“It is time to speak. It is time that veterans use social media, personal demonstration, and activism to make change happen instead of waiting on it.” In every Veterans Administration job announcement, there is a copy of the VA’s mission statement. … Continue reading

Posted in Advocacy, Media | Tagged , , , , | Leave a comment